ORBIMED ADVISORS LLC 13D and 13G filings for Disc Medicine, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-12 7:57 pm Sale | 2025-03-10 | 13D | Disc Medicine, Inc. IRON | ORBIMED ADVISORS LLC | 1,556,369 4.500% | -229,202 (-12.84%) | Filing |
| 2024-06-20 5:15 pm Purchase | 2024-06-17 | 13D | Disc Medicine, Inc. IRON | ORBIMED ADVISORS LLC | 1,785,571 6.000% | 83,334 (+4.90%) | Filing |
| 2023-12-15 4:48 pm Sale | 2023-12-13 | 13D | Disc Medicine, Inc. IRON | ORBIMED ADVISORS LLC | 1,702,237 7.100% | -567,400 (-25.00%) | Filing |
| 2023-06-21 4:53 pm Purchase | 2023-06-16 | 13D | Disc Medicine, Inc. IRON | ORBIMED ADVISORS LLC | 2,269,637 10.200% | 108,696 (+5.03%) | Filing |
| 2023-01-03 5:23 pm Purchase | 2022-12-29 | 13D | Disc Medicine, Inc. IRON | ORBIMED ADVISORS LLC | 2,160,941 12.800% | 2,160,941 (New Position) | Filing |